Veracyte | VCYT - Net Income


Veracyte reported $25.49M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Agenus USD 39.17M 49.8M Mar/2026
Agilent USD 362M 23M Jun/2026
Anika Therapeutics USD 292K 2.62M Dec/2025
Arrowhead Research USD -194.28M 61.55M Jun/2026
Bruker USD -62.9M 66.4M Jun/2026
Heron Therapeutics USD -2.95M 14.54M Dec/2025
Illumina USD 207M 73M Jun/2026
Karyopharm Therapeutics USD -22.39M 79.81M Mar/2026
Laboratory Of America USD 298.7M 20.9M Jun/2026
Ligand Pharmaceuticals USD 48.51M 61.85M Jun/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
Rigel Pharmaceuticals USD 12.42M 13.45M Sep/2024
Roche Holding CHF 6.87B 1.4B Jun/2026
Sangamo BioSciences USD -36.13M 12.96M Jun/2024
Siemens EUR 2.27B 243M Jun/2026
Sonic Healthcare AUD 236.68M 82.29M Dec/2024
Thermo Fisher Scientific USD 1.74B 85M Jun/2026
Veracyte USD 25.49M 3.22M Jun/2026
Waters USD -136M 64M Jun/2026